Coated microneedles for transdermal delivery HS Gill, MR Prausnitz Journal of controlled release 117 (2), 227-237, 2007 | 815 | 2007 |
Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses S Paust, HS Gill, BZ Wang, MP Flynn, EA Moseman, B Senman, ... Nature immunology 11 (12), 1127-1135, 2010 | 788 | 2010 |
Transdermal Delivery of Insulin Using Microneedles in Vivo W Martanto, SP Davis, NR Holiday, J Wang, HS Gill, MR Prausnitz Pharmaceutical research 21, 947-952, 2004 | 672 | 2004 |
Effect of microneedle design on pain in human volunteers HS Gill, DD Denson, BA Burris, MR Prausnitz The Clinical journal of pain 24 (7), 585-594, 2008 | 663 | 2008 |
Coating formulations for microneedles HS Gill, MR Prausnitz Pharmaceutical research 24, 1369-1380, 2007 | 377 | 2007 |
Microneedles permit transdermal delivery of a skin-impermeant medication to humans DP Wermeling, SL Banks, DA Hudson, HS Gill, J Gupta, MR Prausnitz, ... Proceedings of the National Academy of Sciences 105 (6), 2058-2063, 2008 | 355 | 2008 |
Kinetics of skin resealing after insertion of microneedles in human subjects J Gupta, HS Gill, SN Andrews, MR Prausnitz Journal of controlled release 154 (2), 148-155, 2011 | 341 | 2011 |
Coated microneedles for drug delivery to the eye J Jiang, HS Gill, D Ghate, BE McCarey, SR Patel, HF Edelhauser, ... Investigative ophthalmology & visual science 48 (9), 4038-4043, 2007 | 312 | 2007 |
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge Q Zhu, VG Zarnitsyn, L Ye, Z Wen, Y Gao, L Pan, I Skountzou, HS Gill, ... Proceedings of the National Academy of Sciences 106 (19), 7968-7973, 2009 | 234 | 2009 |
Gold nanoparticle–M2e conjugate coformulated with CpG induces protective immunity against influenza A virus W Tao, KS Ziemer, HS Gill Nanomedicine 9 (2), 237-251, 2014 | 191 | 2014 |
Does needle size matter? HS Gill, MR Prausnitz Journal of diabetes science and technology 1 (5), 725-729, 2007 | 187 | 2007 |
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine HS Gill, J Söderholm, MR Prausnitz, M Sällberg Gene therapy 17 (6), 811-814, 2010 | 176 | 2010 |
Mucosal vaccine delivery: Current state and a pediatric perspective AK Shakya, MYE Chowdhury, W Tao, HS Gill Journal of controlled release 240, 394-413, 2016 | 156 | 2016 |
An electrically active microneedle array for electroporation SO Choi, YC Kim, JH Park, J Hutcheson, HS Gill, YK Yoon, MR Prausnitz, ... Biomedical microdevices 12, 263-273, 2010 | 139 | 2010 |
Microneedle coating methods: A review with a perspective RSJ Ingrole, HS Gill Journal of Pharmacology and Experimental Therapeutics 370 (3), 555-569, 2019 | 126 | 2019 |
Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses W Tao, BL Hurst, AK Shakya, MJ Uddin, RSJ Ingrole, ... Antiviral research 141, 62-72, 2017 | 124 | 2017 |
5-Aminolevulinic acid coated microneedles for photodynamic therapy of skin tumors AK Jain, CH Lee, HS Gill Journal of Controlled Release 239, 72-81, 2016 | 117 | 2016 |
Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity Y Ma, W Tao, SJ Krebs, WF Sutton, NL Haigwood, HS Gill Pharmaceutical research 31, 2393-2403, 2014 | 116 | 2014 |
Selective removal of stratum corneum by microdermabrasion to increase skin permeability HS Gill, SN Andrews, SK Sakthivel, A Fedanov, IR Williams, DA Garber, ... European Journal of Pharmaceutical Sciences 38 (2), 95-103, 2009 | 111 | 2009 |
M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection W Tao, HS Gill Vaccine 33 (20), 2307-2315, 2015 | 107 | 2015 |